The World Market for Cancer Diagnostics, 5th Edition - Kalorama Information
The World Market for Cancer Diagnostics, 5th
Edition: Precision and Personalized Testing Arrives
Kalorama Information Presents
A Short Preview
MarketResearch.com provides market research solutions to business professionals
seeking to enhance their business goals. We provide a number of business intelligence
solutions, from individual market research reports from over 700 leading global
publishers, to Knowledge Centers where clients can discover deeper business insight
products into a topic over time. Or perhaps your business needs a much wider view across
multiple industries and topics, if so, our Profound solution allows you to select specific
parts (graphs, tables, charts or sections) from different market research reports.
Our Account Managers have in-depth knowledge of the publishers and the various types
of reports in their respective industries. They give you unbiased and qualitative insights on
which reports will best meet your needs.
To learn more about which Market Intelligence Solution might best fit your needs, contact
us for a complimentary Business Intelligence Assessment. One of our Account Managers
will get right back in touch with you.
About Kalorama Information
For more than 30 years, Kalorama Information has been a leading publisher of market
research in medical markets, including the biotechnology, diagnostics, healthcare, medical
device, and pharmaceutical industries. Our comprehensive, timely, quality research and
innovative approach to analysis and presentation of market intelligence have made
Kalorama Information a premier source of market information for top industry decision
Kalorama Information’s reports track medical market trends, survey market players, and
provide a comprehensive analysis of each market with both the vital market data and
cogent, plain-English interpretation and insight.
Our research is written by industry experts who offer insight on industry structure and
competitive landscape, technology assessment and penetration, and emerging products
and trends. Their analysis is based on both primary and secondary research as well as
years of professional expertise in their respective industries. In addition to analyzing
current and historical trends, our analysts predict where the market is headed over the
next five to ten years.
The World Market for Cancer Diagnostics, 5th Edition:
Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and
molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and
early detection of cancer recurrence. The market for cancer testing are comprehensively covered in
Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition.
The phenomenon of test personalization comes under many guises –
pharmacogenomic, pharmacogenetic, companion tests, and represents one of the fastest growing
segments of the market for cancer tests. It has emerged fully from research into clinical practice.
Instrumentation now automates many of the sample preparation and assay steps that were formerly
labor intensive. New tests are being launched all the time. Some personalized cancer tests are CE
Marked and FDA-cleared and many more are in development. More and more laboratories offer
complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions.
Government and private healthcare payers have recognized the value of new molecular tools and are
agreeing to pay for them.
This report is written from the point of view of diagnostic modalities for the detection and
management of cancer and in particular solid tumors. The technology to detect cancers of the blood -
lymphomas, myelomas and leukemias - is mature and well established. The routine complete blood
count screens for blood cell abnormalities and is followed by bone marrow analysis and flow
cytometric studies of the blood cell surface markers. These to arrive at a more specific diagnosis. As
such this report does not discuss area of hematological cancer diagnosis in great detail.
Cancer Diagnostics TOC Highlights
o Cancer - Diagnosis And Therapy Management
o Market Issues in the Commercialization of Cancer Diagnostics
o Technological Trends that Enable the Future of Cancer Diagnostics
o Market Analysis – Cancer Testing
o Cancer Tests in Clinical Chemistry
o Immunoassay Cancer Tests
o Tissue – and Cell-based Cancer Tests
o Personalized Cancer Testing Advances in Precisiong Skin Care Over
For More on this Report and Additional Research